• No results found

Effect of Late-Preterm Birth and Maternal Medical Conditions on Newborn Morbidity Risk

N/A
N/A
Protected

Academic year: 2020

Share "Effect of Late-Preterm Birth and Maternal Medical Conditions on Newborn Morbidity Risk"

Copied!
12
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

TABLE 1Non–Life-Threatening ICD-9-CM Diagnostic Conditionsand Codes From Infant Hospital Discharge Data
TABLE 2Maternal Medical Conditions Classification Based on ICD-9-CM Diagnostic Codes on the Hospital Discharge Record or a Maternal Riskor Complication on the Infant Birth Certificate
FIGURE 1
TABLE 3Select Characteristics of Term and Late-Preterm Newborns and Proportion With MorbidityDuring Birth Hospitalization: Massachusetts, 1998–2003
+2

References

Related documents

Figure 5 Intercept yield stress (mean ± standard error [SE]) obtained from general linear regression analysis at 350 g kg −1 water content (see Table 5) of soil treated with barley

In essence, model ( 3.8 ) and its constraints im- posed both integer and real restrictions on inputs and undesirable outputs whilst weak disposability influences the output set..

( B – E ) Competition-based assays and Western blotting to evaluate the effect of TRIM33 shRNAs on B-ALL, 38B9, acute myeloid leukemia (AML), or T-cell acute lymphoblastic

Method — An original adaptation of the meshDOG detector to the case of face meshes; The adaptation and comparison of three mesh descriptors to the case of 3D faces and their use

This is the sixth volume in the series Drawings in Swedish Public Collections and the second devoted to Italian Drawings Catalogue raisonné Nationalmuseum NVVU Text in English Hb,

The significant reduction of CD56 dim NK subsets in peripheral blood and in the tumor regions compared to non-tumor regions in the HCC patients with reduced levels of

Using univariate analysis, factors associated with NIV failure and in-ICU mortality were similar and included SAPS II, immunosuppression, bilateral lung infiltrates, ARDS, and

Figure 7 Dz13 downregulates target c-Jun levels in ectopic oste- osarcoma, prostate and breast tumours.. Ectopic osteosarcoma (G292), prostate (PC3) and breast (MDA-MB231)